Iron‐dependent cell death of hepatocellular carcinoma cells exposed to sorafenib

C Louandre, Z Ezzoukhry, C Godin… - … journal of cancer, 2013 - Wiley Online Library
The multikinase inhibitor sorafenib is currently the treatment of reference for advanced
hepatocellular carcinoma (HCC). In our report, we examined the cytotoxic effects of sorafenib on …

The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells

C Louandre, I Marcq, H Bouhlal, E Lachaier, C Godin… - Cancer letters, 2015 - Elsevier
… Sorafenib treatment of Balb/c nude mice that received tumour xenografts derived from HCC
cells with reduced Rb levels resulted in complete tumour regression in 50% of the animals …

EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib

…, C Louandre, E Trécherel, C Godin… - … journal of cancer, 2012 - Wiley Online Library
Sorafenib is currently the medical treatment of reference for hepatocellular carcinoma (HCC),
but it is not known whether sorafenib is equally active in all HCC. Here, our aim was to …

[HTML][HTML] Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib

A Houessinon, C François, C Sauzay, C Louandre… - Molecular cancer, 2016 - Springer
c Immunoblot analysis of the expression of the MT1 protein. Protein extracts were prepared
from Huh7 cells treated for 4 to 18 h with 10 μM sorafenib. d MT1G mRNA levels were …

[HTML][HTML] Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cells

C Sauzay, C Louandre, S Bodeau, F Anglade… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Sorafenib is the first line treatment for advanced hepatocellular carcinoma (HCC). We explored
its impact on the proteostasis of cancer cells, ie the processes that regulate the synthesis, …

SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma

A Hémon, C Louandre, C Lailler, C Godin… - Biochemical and …, 2020 - Elsevier
C. A heatmap showing the gene expression of ferroptosis genes in HNSCC tumors ranked
according to their increasing mRNA expression of SLC7A11. The gene expression was …

BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinoma

…, C François, C Louandre, C Sabbagh… - Molecular Cancer …, 2010 - AACR
… All samples were kept frozen at −80C. The corresponding protocol was approved by the Comité
de Protection des Personnes 2 Nord-… All inhibitors were kept as stocks in DMSO at −20C. …

Upregulation of BAD, a pro-apoptotic protein of the BCL2 family, in vascular smooth muscle cells exposed to uremic conditions

E Trécherel, C Godin, C Louandre, J Benchitrit… - Biochemical and …, 2012 - Elsevier
… 2C). We did not detect any change in the levels of BAD mRNA in SMC exposed to urea (Fig. …
(C) BAD protein stability. Aortic SMC were treated for 30 min with 50 μM cycloheximide and …

Oxidized low-density lipoprotein elicits an intracellular calcium rise and increases the binding activity of the transcription factor NFAT

…, P Morlière, Z Massy, S Kamel, C Louandre… - Free Radical Biology …, 2005 - Elsevier
… /ml Ham's F10 medium with 5 μM CuSO 4 at 37C for 24 h. Cu 2+ was not removed after …
at 4C for 30 min. After centrifugation at 18,000g for 5 min, the supernatant was kept at −80C. …

Ferroptosis, a new form of cell death relevant to the medical treatment of cancer

…, C Louandre, Z Ezzoukhry, C Godin… - … Sciences: M/S, 2014 - europepmc.org
Ferroptosis is a form of cell death that has recently been reported during exposure to erastin,
a chemical compound identified in a screen for molecules able to kill cancer cells carrying …